A male-to-female gap decreased significantly over time among White and non-Hispanic stone formers, but not among Black stone formers.
Thiazide diuretic therapy prescribed empirically for patients not receiving 24-hour urine testing is significantly associated with reduced odds of urinary stone recurrence compared with alkali citrate and allopurinol, a study found.
Ureteroscopy was used more often during the height of the COVID-19 pandemic compared with before the pandemic and after the peak of the pandemic, according to investigators.
Kidney stone formers with certain hereditary factors had increased risks for more severe disease.
A recent review underscores the possible adverse effects of ketogenic diets, including increased risks for heart disease, cancer, diabetes, and kidney stones.
Modifiable risk factors accounted for only a fraction of the difference in stone rates between the sexes, according to investigators.
Among patients with nephrolithiasis or urolithiasis, the cardiovascular event rate was 74.4 per 1000 person-years.
Tiopronin is indicated for the prevention of cystine stone formation in patients with severe homozygous cystinuria who are unresponsive to treatment with high fluid intake, alkali, and diet modification.
The risk for a first-time symptomatic kidney stone begins to increase in the second trimester and peaks 0 to 3 months after delivery, a study found.
Urologist-gained renal access for percutaneous nephrolithotomy is associated with significantly lower 90-day rates of hospital readmission and blood transfusion compared with radiologist-gained access, a study found.